Relevance of plasma level determination of L-Dopa and 3-O-methyldopa in Parkinson's disease - Discussion

被引：0
|
作者：
Przuntek
Horowski
Riederer
Reichmann
Gerlach
Baas
Eichhorn
Kuhn
Schwarz
Henneberg
Ulm
Gehlen
机构：
来源：
AKTUELLE NEUROLOGIE | 1998年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S282 / S285
页数：4
相关论文
共 50 条
  • [21] The impact of L-DOPA and entacapon therapy on plasma level of homocysteine in Parkinson's disease patients
    Nevrly, M.
    Kanovsky, P.
    Vranova, H.
    Nestrasil, I.
    Langova, K.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2008, 71 (01) : 55 - 60
  • [22] L-dopa plasma levels and executive functions in Parkinson's disease
    Albani, G.
    Cattaldo, S.
    Mori, I.
    Pignatti, R.
    Pradotto, L.
    Mauro, A.
    MOVEMENT DISORDERS, 2009, 24 : S289 - S289
  • [23] URINARY-EXCRETION OF DOPA, 3-O-METHYLDOPA, AND THEIR METABOLITES IN PATIENTS TREATED WITH L-3-O-METHYLDOPA ORALLY
    SHARPLES.NS
    MUENTER, MD
    DINAPOLI, RP
    FEDERATION PROCEEDINGS, 1973, 32 (MAR) : 798 - &
  • [24] L-dopa response in Parkinson's disease - A study with L-dopa infusion test
    Saiki, H.
    Matsumoto, S.
    MOVEMENT DISORDERS, 2012, 27 : S50 - S50
  • [25] Effect of L-dopa on plasma homocysteine in elderly patients with Parkinson' s disease
    王红梅
    China Medical Abstracts (Internal Medicine), 2006, (04) : 227 - 228
  • [26] Plasma lipid peroxidation in sporadic Parkinson's disease: Role of the l-dopa
    Morales, B.
    Salvatierra, J.
    Vives, F.
    Duran, R.
    Barrero, F.
    Agil, A.
    Alba, F.
    Martin, M.
    Peinado, J. M.
    Iribar, M. C.
    Ramirez, M.
    Giner, P.
    MOVEMENT DISORDERS, 2006, 21 : S477 - S477
  • [27] Peculiarities of L-DOPA treatment of Parkinson’s disease
    R. M. Kostrzewa
    P. Nowak
    J. P. Kostrzewa
    R. A. Kostrzewa
    R. Brus
    Amino Acids, 2005, 28 : 157 - 164
  • [28] Monitoring of L-dopa concentrations in Parkinson's disease
    Furlanut, M
    Furlanut, M
    Benetello, P
    PHARMACOLOGICAL RESEARCH, 2001, 43 (05) : 423 - 427
  • [29] L-dopa induced dyskinesia in Parkinson's disease
    Bastide, Matthieu F.
    Bezard, Erwan
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2015, 199 (2-3): : 201 - 212
  • [30] Focusing Effects of L-Dopa in Parkinson's Disease
    Ng, Bernard
    Palmer, Samantha
    Abugharbieh, Rafeef
    McKeown, Martin J.
    HUMAN BRAIN MAPPING, 2010, 31 (01) : 88 - 97
12345